View More View Less
  • 1 University of New Haven, West Haven, CT, USA
Open access

Lyme disease is a tick-borne multisystemic disease caused by Borrelia burgdorferi. Administering antibiotics is the primary treatment for this disease; however, relapse often occurs when antibiotic treatment is discontinued. The reason for relapse remains unknown, but recent studies suggested the possibilities of the presence of antibiotic resistant Borrelia persister cells and biofilms.

In this study, we evaluated the effectiveness of whole leaf Stevia extract against B. burgdorferi spirochetes, persisters, and biofilm forms in vitro. The susceptibility of the different forms was evaluated by various quantitative techniques in addition to different microscopy methods. The effectiveness of Stevia was compared to doxycycline, cefoperazone, daptomycin, and their combinations. Our results demonstrated that Stevia had significant effect in eliminating B. burgdorferi spirochetes and persisters. Subculture experiments with Stevia and antibiotics treated cells were established for 7 and 14 days yielding, no and 10% viable cells, respectively compared to the above-mentioned antibiotics and antibiotic combination. When Stevia and the three antibiotics were tested against attached biofilms, Stevia significantly reduced B. burgdorferi forms. Results from this study suggest that a natural product such as Stevia leaf extract could be considered as an effective agent against B. burgdorferi.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1.

    Radolf JD , Caimano MJ, Stevenson B, Hu LT: Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat Rev Microbiol 10, 8799 (2012)

    • Search Google Scholar
    • Export Citation
  • 2.

    Stricker RB , Johnson L: Lyme disease: The next decade. Infect Drug Resist 4, 19 (2011)

  • 3.

    CDC [Internet]. Lyme Dis website 2014 [cited 2015 Jun 9]; Available from: http://www.cdc.gov/lyme/ststs/index.html

  • 4.

    Donta ST : Tetracycline therapy for chronic Lyme disease. Clin Infect Dis 25 (Suppl 1), S52S56 (1997)

  • 5.

    Massarotti EM , Luger SW, Rahn DW, Messner RP, Wong JB, Johnson RC, et al.: Treatment of early Lyme disease. Am J Med 92, 396403 (1992)

  • 6.

    Dattwyler RJ , Volkman DJ, Conaty SM, Platkin SP, Luft BJ: Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis. Lancet 336, 14041406 (1990)

    • Search Google Scholar
    • Export Citation
  • 7.

    Sapi E , Kaur N, Anyanwu S, Luecke DF, Datar A, Patel S, et al.: Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi. Infect Drug Resist 4, 97113 (2011)

    • Search Google Scholar
    • Export Citation
  • 8.

    Eppes SC , Childs JA: Comparative study of cefuroxime axetil versus amoxicillin in children with early Lyme disease. Pediatrics 109, 11731177 (2002)

    • Search Google Scholar
    • Export Citation
  • 9.

    Centers for Disease Control and Prevention (PTLDS) [Internet]. Lyme Dis website 2014 [cited 2015 Jun 8]; Available from: http://www.cdc.gov/lyme/postlds/index. html

  • 10.

    Berndtson K : Review of evidence for immune evasion and persistent infection in Lyme disease. Int J Gen Med 6, 291306 (2013)

  • 11.

    Bockenstedt LK , Gonzalez DG, Haberman AM, Belperron AA: Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy. J Clin Invest 122, 26522660 (2012)

    • Search Google Scholar
    • Export Citation
  • 12.

    Hodzic E , Feng S, Holden K, Freet KJ, Barthold SW: Persistence of Borrelia burgdorferi following antibiotic treatment in mice. Antimicrob Agents Chemother 52, 17281736 (2008)

    • Search Google Scholar
    • Export Citation
  • 13.

    Diterich I , Rauter C, Kirschning CJ, Hartung T: Borrelia burgdorferi-induced tolerance as a model of persistence via immunosuppression Borrelia burgdorferi-induced tolerance as a model of persistence via immunosuppression. Infect Immun 71, 39793987 (2003)

    • Search Google Scholar
    • Export Citation
  • 14.

    Hodzic E , Imai D, Feng S, Barthold SW: Resurgence of Persisting non-cultivable Borrelia burgdorferi following antibiotic treatment in mice. PLoS One 23, 111 (2014)

    • Search Google Scholar
    • Export Citation
  • 15.

    Barthold SW , Hodzic E, Imai DM, Feng S, Yang X, Luft BJ: Ineffectiveness of tigecycline against persistent Borrelia burgdorferi. Antimicrob Agents Chemother 54, 643651 (2010)

    • Search Google Scholar
    • Export Citation
  • 16.

    Straubinger RK , Summers BA, Chang YF, Appel MJG: Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J Clin Microbiol 35, 111116 (1997)

    • Search Google Scholar
    • Export Citation
  • 17.

    Embers ME , Bartholdk SW, Borda JT, Bowers L, Doyle L, Hodzic E, et al.: Persistence of borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection. PLoS One 7, 112 (2012)

    • Search Google Scholar
    • Export Citation
  • 18.

    Marques A , Telford SR, Turk S-P, Chung E, Williams C, Dardick K, et al.: Xenodiagnosis to detect Borrelia burgdorferi infection: a first-in-human study. Clin Infect Dis 58, 937945 (2014)

    • Search Google Scholar
    • Export Citation
  • 19.

    Klempner MS , Baker PJ, Shapiro ED, Marques A, Dattwyler RJ, Halperin JJ, et al.: Treatment trials for post-lyme disease symptoms revisited. Am J Med 126, 665669 (2013)

    • Search Google Scholar
    • Export Citation
  • 20.

    Fallon BA , Keilp JG, Corbera KM, Petkova E, Britton CB, Dwyer E, et al.: A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 70, 9921003 (2008)

    • Search Google Scholar
    • Export Citation
  • 21.

    Krupp LB , Hyman LG, Grimson R, Coyle PK, Melville P, Ahnn S, et al.: Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 60, 19231930 (2003)

    • Search Google Scholar
    • Export Citation
  • 22.

    Brorson Ø , Brorson S-H, Scythes J, MacAllister J, Wier A, Margulis L: Destruction of spirochete Borrelia burgdorferi round-body propagules (RBs) by the antibiotic tigecycline. Proc Natl Acad Sci U S A 106, 1865618661 (2009)

    • Search Google Scholar
    • Export Citation
  • 23.

    Miklossy J , Kasas S, Zurn AD, McCall S, Yu S, McGeer PL: Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis. J Neuroinflammation 5, 118 (2008)

    • Search Google Scholar
    • Export Citation
  • 24.

    Sapi E , Bastian SL, Mpoy CM, Scott S, Rattelle A, Pabbati N, et al.: Characterization of biofilm formation by Borrelia burgdorferi in vitro. PLoS One 7, 111 (2012)

    • Search Google Scholar
    • Export Citation
  • 25.

    Alban PS , Johnson PW, Nelson DR: Serum-starvation-induced changes in protein synthesis and morphology of Borrelia burgdorferi. Microbiology 146, 119127 (2000)

    • Search Google Scholar
    • Export Citation
  • 26.

    Brorson O , Brorson SH: In vitro conversion of Borrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H medium. Infection 26, 144150 (1998)

    • Search Google Scholar
    • Export Citation
  • 27.

    Vlamakis H , Chai Y, Beauregard P, Losick R, Kolter R: Sticking together: building a biofilm the Bacillus subtilis way. Nat Rev Microbiol 11, 157168 (2013)

    • Search Google Scholar
    • Export Citation
  • 28.

    Stewart PS : Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol 292, 107113 (2002)

  • 29.

    Mah TF : Regulating antibiotic tolerance within biofilm microcolonies. J Bacteriol 194, 47914792 (2012)

  • 30.

    Feng J , Auwaerter PG, Zhang Y: Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline. PLoS One 10, 115 (2015)

    • Search Google Scholar
    • Export Citation
  • 31.

    Feng J , Wang T, Shi W, Zhang S, Sullivan D, Auwaerter PG, et al.: Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library. Emerg Microbes Infect 3, 18 (2014)

    • Search Google Scholar
    • Export Citation
  • 32.

    Cowan MM : Plant products as antimicrobial agents. Clin Microbiol Rev 12, 564582 (1999)

  • 33.

    Datar A , Kaur N, Patel S, Luecke DF, Sapi E: In vitro effectiveness of samento and banderol herbal extracts on the different morphological forms of Borrelia burgdorferi. Townsend Lett (2010)

    • Search Google Scholar
    • Export Citation
  • 34.

    Osman K , Evangelopoulos D, Basavannacharya C, Gupta A, McHugh TD, Bhakta S, et al.: An antibacterial from Hypericum acmosepalum inhibits ATP-dependent MurE ligase from Mycobacterium tuberculosis. Int J Antimicrob Agents 39, 124129 (2012)

    • Search Google Scholar
    • Export Citation
  • 35.

    Zuo GY , An J, Han J, Zhang YL, Wang GC, Hao XY, et al.: Isojacareubin from the Chinese herb Hypericum japonicum: potent antibacterial and synergistic effects on clinical methicillin-resistant Staphylococcus aureus (MRSA). Int J Mol Sci 13, 82108218 (2012)

    • Search Google Scholar
    • Export Citation
  • 36.

    Wangchuk P , Keller PA, Pyne SG, Taweechotipatr M, Tonsomboon A, Rattanajak R, et al.: Evaluation of an ethnopharmacologically selected Bhutanese medicinal plants for their major classes of phytochemicals and biological activities. J Ethnopharmacol 137, 730742 (2011)

    • Search Google Scholar
    • Export Citation
  • 37.

    Clinical studies using natural antimicrobial agents on patients with Lyme disease [Internet] 2007 [cited 2015 Jun 9]; Available from: http://www.nutramedix.ec/ns/lyme-protocol

  • 38.

    Ghosh S , Subudhi E, Nayak S: Antimicrobial assay of Stevia rebaudiana Bertoni leaf extracts against 10 pathogens plant materials and microorganisms determination of minimum inhibitory concentration (MIC). Int J Integrative Biology 2, 2731 (2008)

    • Search Google Scholar
    • Export Citation
  • 39.

    Mohammadi-Sichani, M : Effect of different extracts of Stevia rebaudiana leaves on Streptococcus mutans growth. J Med Plants Res 6, 47314734 (2012)

    • Search Google Scholar
    • Export Citation
  • 40.

    Jayaraman S , Manoharan MS: In-vitro antimicrobial and antitumor activities of Stevia rebaudiana (Asteraceae) Leaf Extracts 7, 11431149 (2008)

    • Search Google Scholar
    • Export Citation
  • 41.

    Siddique AB , Rahman SMM, Hossain MA, Rashid MA: Phytochemical screening and comparative antimicrobial potential of different extracts of Stevia rebaudiana Bertoni leaves. Asian Pacific J Trop Dis 4, 275280 (2014)

    • Search Google Scholar
    • Export Citation
  • 42.

    Puri M , Sharma D: Antibacterial activity of stevioside towards food-borne pathogenic bacteria. Eng Life Sci 11, 326329 (2011)

  • 43.

    Khaybullin RN , Strobykina IY, Dobrynin AB, Gubaydullin AT, Chestnova R V., Babaev VM, et al.: Synthesis and antituberculosis activity of novel unfolded and macrocyclic derivatives of ent-kaurane steviol. Bioorganic Med Chem Lett 22, 69096913 (2012)

    • Search Google Scholar
    • Export Citation
  • 44.

    Hsieh MH , Chan P, Sue YM, Liu JC, Liang TH, Huang TY, et al.: Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: a two-year, randomized, placebo-controlled study. Clin Ther 25, 27972808 (2003)

    • Search Google Scholar
    • Export Citation
  • 45.

    Gregersen S , Jeppesen PB, Holst JJ, Hermansen K: Antihyperglycemic effects of stevioside in type 2 diabetic subjects. Metabolism 53, 7376 (2004)

    • Search Google Scholar
    • Export Citation
  • 46.

    Feng J , Wang T, Zhang S, Shi W, Zhang Y: An Optimized SYBR Green I/PI assay for rapid viability assessment and antibiotic susceptibility testing for Borrelia burgdorferi. PLoS One 9, 18 (2014)

    • Search Google Scholar
    • Export Citation
  • 47.

    Serfaty M , Ibdah M, Fischer R, Chaimovitsh D, Saranga Y, Dudai N: Dynamics of yield components and stevioside production in Stevia rebaudiana grown under different planting times, plant stands and harvest regime. Ind Crops Prod 50, 731736 (2013)

    • Search Google Scholar
    • Export Citation
  • 48.

    Das K , Dang R, Gupta N: Comparative antimicrobial potential of different extracts of leaves of Stevia. Int J Nat Eng Sci 3, 6568 (2009)

    • Search Google Scholar
    • Export Citation
  • 49.

    Kaplan JB : Antibiotic-induced biofilm formation. Int J Artif Organs 34, 737751 (2011)

  • 50.

    Oglesby-Sherrouse AG , Djapgne L, Nguyen AT, Vasil AI, Vasil ML: The complex interplay of iron, biofilm formation, and mucoidy affecting antimicrobial resistance of Pseudomonas aeruginosa. Pathog Dis 70, 307320 (2014)

    • Search Google Scholar
    • Export Citation
  • 51.

    Ciofu O , Tolker-Nielsen T, Jensen , Wang H, Høiby N: Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients. Adv Drug Deliv Rev 85, 723 (2014)

    • Search Google Scholar
    • Export Citation
  • 52.

    Iorio NLP , Caboclo RF, Azevedo MB, Barcellos AG, Neves FPG, Domingues RMCP, et al.: Characteristics related to antimicrobial resistance and biofilm formation of widespread methicillin-resistant Staphylococcus epidermidis ST2 and ST23 lineages in Rio de Janeiro hospitals, Brazil. Diagn Microbiol Infect Dis 72, 3240 (2012)

    • Search Google Scholar
    • Export Citation
  • 53.

    Brooun A , Liu S, Lewis K: A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 44, 640646 (2000)

    • Search Google Scholar
    • Export Citation
  • 54.

    Nisticò R , Piccirilli S, Cucchiaroni ML, Armogida M, Guatteo E, Giampà C, et al.: Neuroprotective effect of hydrogen peroxide on an in vitro model of brain ischaemia. Br J Pharmacol 153, 10221029 (2008)

    • Search Google Scholar
    • Export Citation
  • 55.

    Söderling E , Alaräisänen L, Scheinin A, Mäkinen KK: Effect of xylitol and sorbitol on polysaccharide production by and adhesive properties of Streptococcus mutans. Caries Res 21, 109116 (1987)

    • Search Google Scholar
    • Export Citation
  • 56.

    Allison KR , Brynildsen MP, Collins JJ: Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473, 216220 (2011)

    • Search Google Scholar
    • Export Citation
  • 57.

    Thomas JE , Glade MJ: Stevia: it’s not just about calories. Open Obes J 2, 101109 (2010)

  • 58.

    Anton SD , Martin CK, Han H, Coulon S, Cefalu WT, Geiselman P, et al.: Effects of stevia, aspartame, and sucrose on food intake, satiety, and postprandial glucose and insulin levels. Appetite 55, 3743 (2010)

    • Search Google Scholar
    • Export Citation
  • 59.

    Carakostas MC , Curry LL, Boileau a. C, Brusick DJ: Overview: The history, technical function and safety of rebaudioside A, a naturally occurring steviol glycoside, for use in food and beverages. Food Chem Toxicol 46, 110 (2008)

    • Search Google Scholar
    • Export Citation
  • 60.

    Matsui M , Matsui K, Kawasaki Y, Oda Y, Noguchi T, Kitagawa Y, et al.: Evaluation of the genotoxicity of stevioside and steviol using six in vitro and one in vivo mutagenicity assays. Mutagenesis 11, 573579 (1996)

    • Search Google Scholar
    • Export Citation

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
May 2020 0 196 85
Jun 2020 0 153 140
Jul 2020 0 191 91
Aug 2020 0 188 75
Sep 2020 0 209 90
Oct 2020 0 172 72
Nov 2020 0 0 0